- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on B-cell Chronic Lymphocytic Leukemia
Total 7811 results
-
Royal Marsden NHS Foundation TrustCambridge University Hospitals NHS Foundation Trust; University Hospital Plymouth...UnknownMantle Cell Lymphoma | Chronic Lymphocytic LeukaemiaUnited Kingdom
-
National Cancer Institute (NCI)CompletedB-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States
-
Vilnius UniversityCompletedChronic B-Lymphocytic LeukemiaLithuania
-
National Cancer Institute (NCI)CompletedB-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Novartis PharmaceuticalsCompletedLeukaemiaBelgium, Austria, Czechia, France, Germany, Israel, Russian Federation, Sweden, United Kingdom, Hungary, Ireland, Italy, Slovakia, Bulgaria, Singapore, Ukraine, Poland
-
Gilead SciencesTerminatedB-cell Chronic Lymphocytic Leukemia (CLL) With 17p DeletionUnited States, Spain, Denmark, Belgium, Australia, Poland, Romania, Czechia, Italy, France, Hungary, Austria, Portugal, United Kingdom
-
National Cancer Institute (NCI)TerminatedLeukemia | B-cell Chronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Small Lymphocytic Lymphoma | B-cell Chronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
University Hospital, CaenCNRS, UMR ISTCT 6301, LDM-TEP Groupe, GIP Cyceron, Caen, FranceCompletedUntreated B-Chronic Lymphocytic Leukemia or Diffuse Large B Cells Lymphoma PatientsFrance
-
Genentech, Inc.CompletedLymphocytic Leukemia, Chronic, Diffuse Large B-Cell LymphomaUnited States, Australia
-
National Cancer Institute (NCI)TerminatedB-cell Chronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Astellas Pharma International B.V.TerminatedChronic Lymphocytic Leukaemia (CLL) | Indolent Non Hodgkin's Lymphoma (iNHL)Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates
-
Hoffmann-La RocheTerminatedB-Cell Chronic Lymphocytic LeukemiaItaly, Spain, Israel, United Kingdom, Latvia
-
Prof. Dr. Med. Laimonas GriskeviciusCompletedB-Cell Chronic Lymphocytic LeukemiaLithuania
-
CelgeneCompletedLeukemia Lymphocytic Chronic B-CellUnited States, Austria
-
CelgeneCompletedB-Cell Chronic Lymphocytic LeukemiaUnited States, Spain, Australia, Belgium, Italy, Serbia, Poland, Israel, New Zealand, Portugal, Brazil, France, Bulgaria, Croatia, Czechia, Hungary, Russian Federation, Netherlands, Romania, Denmark, United Kingdom, Austria, Canada, South... and more
-
Janssen-Cilag Farmaceutica Ltda.Approved for marketingB-cell Chronic Lymphocytic LeukemiaBrazil
-
Southwest Oncology GroupNational Cancer Institute (NCI)Withdrawn
-
SBI Biotech Co., Ltd.Terminated
-
Genzyme, a Sanofi CompanyCompletedB-Cell Chronic Lymphocytic LeukemiaSweden, United States, Croatia, Canada, Ukraine, Austria, Bulgaria, France, Germany, Greece, Italy, Poland, Portugal, Romania, Russian Federation
-
BayerCompleted
-
BiogenTerminatedB-Cell Chronic Lymphocytic LeukemiaUnited States
-
Chronic Lymphocytic Leukemia Research ConsortiumBayerUnknownB-Cell Chronic Lymphocytic LeukemiaUnited States
-
Genitope CorporationTerminatedB-Cell Chronic Lymphocytic Leukemia
-
National Health Research Institutes, TaiwanCompletedChronic Lymphocytic Leukemia (CLL)
-
XEME Biopharma Inc.National Cancer Institute (NCI)Active, not recruitingChronic Lymphocytic Leukemia (CLL)United States
-
University Health Network, TorontoNovartisCompletedChronic Lymphocytic Leukemia (CLL)Canada
-
MedImmune LLCCompletedChronic Lymphocytic Leukemia (CLL)United States, France, Italy, Poland, Canada, Israel, Germany, Belgium
-
Gilead SciencesApproved for marketingChronic Lymphocytic Leukemia (CLL)United States, Italy, United Kingdom, Ireland
-
GlaxoSmithKlineCompleted
-
Inhye AhnBayerWithdrawnChronic Lymphocytic Leukemia (CLL)
-
Aptevo TherapeuticsCompletedChronic Lymphocytic Leukemia (CLL)United States, Austria, Germany, Poland, Spain
-
Dartmouth-Hitchcock Medical CenterTerminatedChronic Lymphocytic Leukemia (CLL)United States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedChronic Lymphocytic Leukemia (CLL)United States
-
Nevada Cancer InstituteGlaxoSmithKline; CephalonWithdrawnChronic Lymphocytic Leukemia (CLL)United States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
Northwell HealthTerminated
-
CytRxCompletedB-Cell Chronic Lymphocytic LeukemiaUnited States
-
Cylene PharmaceuticalsWithdrawnB-Cell Chronic Lymphocytic LeukemiaUnited States
-
Molecular Templates, Inc.WithdrawnSmall Lymphocytic Leukemia | Chronic B-cell Lymphocytic Leukemia
-
Celgene CorporationCompletedLeukemia Lymphocytic Chronic B-CellUnited States, Germany
-
Pharmacyclics LLC.CompletedB-cell Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Pharmacyclics LLC.CompletedB-cell Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Hoffmann-La RocheCompletedLymphocytic Leukemia, ChronicBelarus, Poland
-
National Cancer Institute (NCI)CompletedB-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
AbbVieTerminatedChronic Lymphocytic Leukemia (CLL)Russian Federation
-
Pharmacyclics LLC.Janssen, LPCompletedChronic Lymphocytic Leukemia (CLL)United States
-
Gilead SciencesBoehringer IngelheimTerminatedChronic Lymphocytic Leukemia (CLL)United States
-
University of PeloponneseNational and Kapodistrian University of Athens; Harokopio UniversityCompleted
-
Merck Sharp & Dohme LLCCompletedChronic Lymphocytic Leukemia (CLL)